Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 21, 2025
Multimodal chemoradiotherapy including interstitial brachytherapy enhances outcomes in FIGO stage IVA cervical cancer: a focus on tumor control and quality of lifeMaria Neu, Carolin Michaela Wöhrl, Renate Walter, et al.
Archives of Gynecology and Obstetrics|April 14, 2017
Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trialTheresa M Kolben, Florian Bergauer, Jochen Moeckel, et al.
International Journal of Molecular Sciences|February 11, 2023
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical CancerFabian Garrido, Carl Mathis Wild, Udo Jeschke, et al.
Archives of Gynecology and Obstetrics|November 27, 2024
Review on Symptomatic pedunculated leiomyomas in pregnancy with special consideration of an example caseJonas Bubmann, Carl Mathis Wild, Christian Dannecker, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
The Role of Chemokines in Cervical CancersFabian Garrido, Carl Mathis Wild, Johanna Mittelberger, et al.
Cancers|April 3, 2021
EP4 as a Negative Prognostic Factor in Patients with Vulvar CancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
Future Oncology (London, England)|September 21, 2016
Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasiaTheresa M Kolben, Franziska Kraft, Thomas Kolben, et al.
Oncology Letters|November 1, 2017
The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancerAnnika Stiasny, Christoph P Freier, Christina Kuhn, et al.
International Journal of Molecular Sciences|May 14, 2022
Seroma after Simple Mastectomy in Breast Cancer-The Role of CD4+ T Helper Cells and the Evidence as a Possible Specific Immune ProcessNicole Pochert, Mariella Schneider, Nadine Ansorge, et al.
Pageof 8